Case of human immunodeficiency virus infection presenting as a tip variant of focal segmental glomerulosclerosis: A case report and review of the literature

Table 1 Laboratory data at the time of administration

Hematology		Blood chemistry		Immunology		Urinalysis
WBC	7720/µL	Na	133 mEq/L	CRP	0.27 mg/dL	Protein	11.28 g/24 h
CD4	549/µL	K	4.1 mEq/L	IgG	426 mg/dL	Sugar	3+
RBC	567 × 104/µL	Cl	106 mEq/L	IgA	293 mg/dL	Occult blood	3+
Hb	18.9 g/dL	Ca	7.2 mg/dL	IgM	83 mg/dL	Urinary RBC	5-9/HPF
Hct	53.20%	Pi	2.6 mg/dL	CH50	48.7 U/mL	β2MG	65500 g/L
Plt	42.5 × 104/µL	BUN	20.1 mg/dL	C3	159 mg/dL	NAG	173.2 IU/L
		sCr	1.99 mg/dL	C4	42 mg/dL	Crystal	(-)
		UA	4.4 mg/dL	ANA	40 ×
		LDH	243 IU/L	MPO-ANCA	< 1.0 U/mL
		AST	23 IU/L	PR3-ANCA	< 1.0 U/mL
		ALT	20 IU/L	anti-GBM Ab	< 2.0 U/mL
		TP	3.9 g/dL
		Alb	0.8 g/dL
		LDL-cho	418 mg/dL
		BS	121 mg/dL
		HIV RNA	(-)
		HBS Ag	(-)
		HCV Ab	(-)

CD: Cluster of differentiation; BUN: Blood urea nitrogen; sCr: Serum creatinine; UA: Uric acid; LDH: Lactate dehydrogenase; AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; LDL-cho: Low-density lipoprotein cholesterol; HIV: Human immunodeficiency virus; HBS Ag: Hepatitis B virus surface antigen; HCV Ab: Hepatitis C virus antibody; CRP: C-reactive protein; CH50: Total complement activity; ANA: Anti-nuclear antibody; MPO-ANCA: Myeloperoxidase-antineutrophil cytoplasmic antibody; PR3-ANCA: Proteinase 3-antineutrophil cytoplasmic antibody; Anti-GBM ab: Anti-glomerular basement membrane antibody; HPF: High power field; β2MG: β2 microglobulin; NAG: N-acetylglucosaminidase.